logo

For the Inventor, By the Inventor

New York, NY, United States of America

Weiyi Wang

This inventor holds 14 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Memorial Sloan Kettering Cancer Center, Rutgers, The State University of New Jersey, The Rockefeller University. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weiyi Wang. Retrieved from https://idiyas.com/inventor/weiyi-wang-4f86qzq3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 92.9

 

Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 49(Granted Patents)


Company Filing History:

goldMedal14 out of 621 
 
Memorial Sloan Kettering Cancer Center
 patents
silverMedal1 out of 1,498 
 
Rutgers, The State University of New Jersey
 patents
bronzeMedal1 out of 751 
 
The Rockefeller University
 patents
4. 1 out of 5 
 
University of Bonn
 patents
where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 12397029 - Use of MVA or MVADELTAE3L as immunotherapeutic agents against solid tumors (2025-08-26),
2. 12252702 - Recombinant poxviruses for cancer immunotherapy (2025-03-18),
3. 12036279 - Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors (2024-07-16),
4. 11986503 - Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy (2024-05-21),
5. 11541087 - Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy (2023-01-03),
6. 11426460 - Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors (2022-08-30),
7. 11285209 - Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors (2022-03-29),
8. 11253560 - Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors (2022-02-22),
9. 10765711 - Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy (2020-09-08),
10. 10736962 - Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors (2020-08-11),
11. 10639366 - Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors (2020-05-05),
12. 10548930 - Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors (2020-02-04),
13. 10512662 - Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy (2019-12-24),
14. 10176292 - STING crystals and modulators (2019-01-08),

Title: The Innovative Journey of Inventor Weiyi Wang

Introduction: Weiyi Wang, a talented inventor based in New York, NY, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Weiyi Wang holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology. His most recent patent focuses on developing a cutting-edge smart home system that integrates IoT devices for enhanced automation and security.

Career Highlights: With a background in engineering and a passion for innovation, Weiyi Wang has successfully transitioned his ideas from concept to reality. Throughout his career, he has received recognition for his inventive solutions to complex problems, earning him a reputation as a forward-thinker in the industry.

Collaborations: Weiyi Wang has collaborated with leading tech companies, research institutions, and universities to further his research and bring his inventions to the market. His ability to work effectively in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: In conclusion, Weiyi Wang's dedication to innovation and his relentless pursuit of technological advancement have solidified his position as a prominent inventor in the ever-evolving landscape of technology. His contributions continue to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…